Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zaremba

Showing results (731-740 of 967) with videos related to

Pageof 97
Sort By:
Journal for Immunotherapy of Cancer|May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.
European Journal of Immunology|September 1, 1995
Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21S I Abrams, M J Dobrzanski, D T Wells, et al.
Medycyna Wieku Rozwojowego|October 20, 2009
[Detection of rare mutations in the dystrophin gene]Janusz G Zimowski, Mariola Holding, Elzbieta Fidziańska, et al.
Neurologia I Neurochirurgia Polska|March 29, 2018
Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patientsAnna Sulek, Anna Lusakowska, Wioletta Krysa, et al.
Nature Biotechnology|April 16, 2013
Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cellsFadi J Najm, Angela M Lager, Anita Zaremba, et al.
Nature|May 7, 2015
Complex archaea that bridge the gap between prokaryotes and eukaryotesAnja Spang, Jimmy H Saw, Steffen L Jørgensen, et al.
Neurologia I Neurochirurgia Polska|June 9, 2018
WITHDRAWN: Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patientsAnna Sulek, Anna Lusakowska, Wioletta Krysa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 26, 2008
Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imagingLaura-Adela Harsan, Jérôme Steibel, Anita Zaremba, et al.
Nature Neuroscience|September 5, 2017
Impaired hippocampal place cell dynamics in a mouse model of the 22q11.2 deletionJeffrey D Zaremba, Anastasia Diamantopoulou, Nathan B Danielson, et al.
Pharmacoeconomics|July 7, 2021
Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and TisagenlecleucelKaren M Facey, Jaime Espin, Emma Kent, et al.
Pageof 97

Showing results (731-740 of 967) with videos related to

Sort By:
Pageof 97
Journal for Immunotherapy of Cancer|May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.
European Journal of Immunology|September 1, 1995
Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21S I Abrams, M J Dobrzanski, D T Wells, et al.
Medycyna Wieku Rozwojowego|October 20, 2009
[Detection of rare mutations in the dystrophin gene]Janusz G Zimowski, Mariola Holding, Elzbieta Fidziańska, et al.
Neurologia I Neurochirurgia Polska|March 29, 2018
Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patientsAnna Sulek, Anna Lusakowska, Wioletta Krysa, et al.
Nature Biotechnology|April 16, 2013
Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cellsFadi J Najm, Angela M Lager, Anita Zaremba, et al.
Nature|May 7, 2015
Complex archaea that bridge the gap between prokaryotes and eukaryotesAnja Spang, Jimmy H Saw, Steffen L Jørgensen, et al.
Neurologia I Neurochirurgia Polska|June 9, 2018
WITHDRAWN: Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patientsAnna Sulek, Anna Lusakowska, Wioletta Krysa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 26, 2008
Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imagingLaura-Adela Harsan, Jérôme Steibel, Anita Zaremba, et al.
Nature Neuroscience|September 5, 2017
Impaired hippocampal place cell dynamics in a mouse model of the 22q11.2 deletionJeffrey D Zaremba, Anastasia Diamantopoulou, Nathan B Danielson, et al.
Pharmacoeconomics|July 7, 2021
Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and TisagenlecleucelKaren M Facey, Jaime Espin, Emma Kent, et al.
Pageof 97